Autochecked users, Comment administrators, Editors, Interface administrators, Reviewers, Suppressors, Administrators, Widget editors
1,874
edits
Changes
HAEM5:Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (view source)
Revision as of 17:01, 4 December 2023
, 17:01, 4 December 2023no edit summary
{{Under Construction}}
{{Under Construction}}
<blockquote class='blockedit'>{{Box-round|title=HAEM5 Conversion Notes|This page was converted to the new template on 2023-11-30. The original page can be found at [[HAEM4:Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)]].
<blockquote class='blockedit'>{{Box-round|title=HAEM5 Conversion Notes|This page was converted to the new template on 2023-12-04. The original page can be found at [[HAEM4:Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)]].
}}</blockquote>
}}</blockquote>
==Primary Author(s)*==
==Primary Author(s)*==
*7-8% of all B cell lymphoma <ref>{{Cite journal|last=Kuper-Hommel|first=Marion J. J.|last2=van de Schans|first2=Saskia A. M.|last3=Vreugdenhil|first3=Gerard|last4=van Krieken|first4=J. Han J. M.|last5=Coebergh|first5=Jan Willem W.|date=2013-09|title=Trends in incidence, therapy and outcome of localized nodal and extranodal marginal zone lymphomas: declining incidence and inferior outcome for gastrointestinal sites|url=https://pubmed.ncbi.nlm.nih.gov/23302044|journal=Leukemia & Lymphoma|volume=54|issue=9|pages=1891–1897|doi=10.3109/10428194.2013.764421|issn=1029-2403|pmid=23302044}}</ref>
*7-8% of all B cell lymphoma <ref>{{Cite journal|last=Kuper-Hommel|first=Marion J. J.|last2=van de Schans|first2=Saskia A. M.|last3=Vreugdenhil|first3=Gerard|last4=van Krieken|first4=J. Han J. M.|last5=Coebergh|first5=Jan Willem W.|date=2013-09|title=Trends in incidence, therapy and outcome of localized nodal and extranodal marginal zone lymphomas: declining incidence and inferior outcome for gastrointestinal sites|url=https://pubmed.ncbi.nlm.nih.gov/23302044|journal=Leukemia & Lymphoma|volume=54|issue=9|pages=1891–1897|doi=10.3109/10428194.2013.764421|issn=1029-2403|pmid=23302044}}</ref>
**Group of Marginal zone lymphomas: [[Nodal Marginal Zone Lymphoma]], [[Splenic Marginal Zone Lymphoma]], MALT lymphoma
**Group of Marginal zone lymphomas: [[HAEM5:Nodal marginal zone lymphoma]], [[HAEM5:Splenic marginal zone lymphoma]], MALT lymphoma
*50% of primary gastric lymphoma <ref>{{Cite journal|last=Doglioni|first=C.|last2=Wotherspoon|first2=A. C.|last3=Moschini|first3=A.|last4=de Boni|first4=M.|last5=Isaacson|first5=P. G.|date=1992-04-04|title=High incidence of primary gastric lymphoma in northeastern Italy|url=https://pubmed.ncbi.nlm.nih.gov/1347858|journal=Lancet (London, England)|volume=339|issue=8797|pages=834–835|doi=10.1016/0140-6736(92)90280-g|issn=0140-6736|pmid=1347858}}</ref><ref>{{Cite journal|last=Isaacson|first=Peter G.|last2=Du|first2=Ming-Qing|date=2004-08|title=MALT lymphoma: from morphology to molecules|url=https://pubmed.ncbi.nlm.nih.gov/15286744|journal=Nature Reviews. Cancer|volume=4|issue=8|pages=644–653|doi=10.1038/nrc1409|issn=1474-175X|pmid=15286744}}</ref>
*50% of primary gastric lymphoma <ref>{{Cite journal|last=Doglioni|first=C.|last2=Wotherspoon|first2=A. C.|last3=Moschini|first3=A.|last4=de Boni|first4=M.|last5=Isaacson|first5=P. G.|date=1992-04-04|title=High incidence of primary gastric lymphoma in northeastern Italy|url=https://pubmed.ncbi.nlm.nih.gov/1347858|journal=Lancet (London, England)|volume=339|issue=8797|pages=834–835|doi=10.1016/0140-6736(92)90280-g|issn=0140-6736|pmid=1347858}}</ref><ref>{{Cite journal|last=Isaacson|first=Peter G.|last2=Du|first2=Ming-Qing|date=2004-08|title=MALT lymphoma: from morphology to molecules|url=https://pubmed.ncbi.nlm.nih.gov/15286744|journal=Nature Reviews. Cancer|volume=4|issue=8|pages=644–653|doi=10.1038/nrc1409|issn=1474-175X|pmid=15286744}}</ref>
*Median age 70<sup>th</sup> decade, F:M=1:1 with site specific sex differences; female predominance in thyroid and salivary glands <ref>{{Cite journal|date=1997-06-01|title=A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project|url=https://pubmed.ncbi.nlm.nih.gov/9166827|journal=Blood|volume=89|issue=11|pages=3909–3918|issn=0006-4971|pmid=9166827}}</ref>
*Median age 70<sup>th</sup> decade, F:M=1:1 with site specific sex differences; female predominance in thyroid and salivary glands <ref>{{Cite journal|date=1997-06-01|title=A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project|url=https://pubmed.ncbi.nlm.nih.gov/9166827|journal=Blood|volume=89|issue=11|pages=3909–3918|issn=0006-4971|pmid=9166827}}</ref>
==Links==
==Links==
[[Nodal Marginal Zone Lymphoma]]
[[HAEM5:Nodal marginal zone lymphoma]]
[[Splenic Marginal Zone Lymphoma]]
[[HAEM5:Splenic marginal zone lymphoma]]
==References==
==References==